Avita Medical | 1811094D - 贷款资金



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 437.17M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


贷款资金 更改 日
Accuray USD 124.78M 2.54M 2025-12
Celltrion KRW 411.27B 998.23M 2026-03
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD 2.66M 153K 2025-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 126K 425K 2026-06
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
Pharma Mar EUR 32.13M 1.04M 2026-06
Polynovo AUD 15.39M 663K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Qiagen NV USD 1.63B 19.45M 2026-06
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 404.17M 248K 2026-03
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Telix Pharmaceuticals AUD 564.44M 115.99M 2026-06
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 172.8M 9.49M 2026-06